Same-Day Colectomy for Colon Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a same-day colectomy, a surgery to remove part of the colon, can effectively treat colon cancer. Researchers aim to determine if patients can safely return home the same day after the procedure. The trial is ideal for individuals who can perform daily activities without breathlessness and have stable blood pressure and diabetes managed with oral medication. Participants must have a caregiver at home after surgery and access to a phone or computer. As an unphased trial, this study provides a unique opportunity to contribute to advancements in innovative surgical care.
Do I have to stop taking my current medications for the trial?
You will need to stop taking anti-platelet medications like aspirin and clopidogrel 7 days before the surgery and can restart them the day after surgery. The protocol does not specify other medications, so it's best to discuss with the trial team.
What prior data suggests that same-day colectomy is safe for patients undergoing colon and rectal surgery?
Studies have shown that same-day colectomy, where patients go home the same day after surgery, can be safe for some individuals. In one study, nearly half of the 86 patients who had a planned colectomy left the hospital the same day without any problems. Another report found that almost 60 patients successfully followed these guidelines, achieving positive results.
Additionally, the short-term risks of this procedure, such as serious health issues or needing to return to the hospital, were generally low. Patients did not face major issues within 30 days after surgery. This suggests that same-day colectomy might be a well-tolerated option for some patients needing colon surgery.12345Why are researchers excited about this trial?
Researchers are excited about the Same-Day Colectomy for colon cancer because it could significantly reduce recovery time and hospital stays compared to traditional colectomy procedures. Standard treatments often require several days of hospitalization, but this approach aims to let patients go home the same day, potentially improving patient comfort and reducing healthcare costs. Additionally, a quicker recovery may lead to faster return to daily activities, which is a significant benefit for patients' quality of life.
What evidence suggests that same-day colectomy is effective for colon cancer?
Research has shown that some patients can safely go home the same day after a minimally invasive colectomy, a surgery to remove part of the colon. Studies report success rates ranging from 22% to 98%, indicating effectiveness for some individuals. One study found that about 22% to 35% of patients were able to leave the hospital within 24 hours. The trial will evaluate the effectiveness and safety of the Same-Day Colectomy approach. This method is safe for certain patients and might help reduce healthcare costs. Although it does not significantly change short-term quality of life compared to traditional methods, it still offers promising results for those who qualify.13467
Who Is on the Research Team?
Eugene Kim, MD
Principal Investigator
University of Arizona
Are You a Good Fit for This Trial?
This trial is for adults aged 18-70 who need certain types of colon surgery and are in good physical condition with well-controlled blood pressure or diabetes. They must have a caregiver, access to technology, and be able to complete educational sessions before and after surgery. Smokers, those with severe heart, lung or kidney conditions, or complex surgical histories are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo outpatient colorectal surgery (same-day colectomy)
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Same-Day Colectomy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arizona
Lead Sponsor